These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 31360110
21. Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction. Khan M, Li T, Ahmad Khan MK, Rasul A, Nawaz F, Sun M, Zheng Y, Ma T. Biomed Res Int; 2013; 2013():719858. PubMed ID: 23533997 [Abstract] [Full Text] [Related]
22. Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells. Kang X, Wang H, Li Y, Xiao Y, Zhao L, Zhang T, Zhou S, Zhou X, Li Y, Shou Z, Chen C, Li B. Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1961-1970. PubMed ID: 31116036 [Abstract] [Full Text] [Related]
23. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells. Chun J, Li RJ, Cheng MS, Kim YS. Cancer Lett; 2015 Feb 01; 357(1):393-403. PubMed ID: 25434800 [Abstract] [Full Text] [Related]
24. Metformin revert insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells. Liu C, Liu Q, Yan A, Chang H, Ding Y, Tao J, Qiao C. Cancer Med; 2020 Jun 01; 9(11):3875-3884. PubMed ID: 32248666 [Abstract] [Full Text] [Related]
25. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway. Xu R, Yin J, Zhang Y, Zhang S. J Cell Biochem; 2019 Sep 01; 120(9):14585-14593. PubMed ID: 30998268 [Abstract] [Full Text] [Related]
26. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion. Wei W, Huang H, Zhao S, Liu W, Liu CX, Chen L, Li JM, Wu YL, Yan H. Apoptosis; 2013 Sep 01; 18(9):1060-70. PubMed ID: 23613107 [Abstract] [Full Text] [Related]
27. In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cells. Chikamatsu S, Saijo K, Imai H, Narita K, Kawamura Y, Katoh T, Ishioka C. Cancer Med; 2019 Sep 01; 8(12):5662-5672. PubMed ID: 31364822 [Abstract] [Full Text] [Related]
28. Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation. Nakatani K, Maehama T, Nishio M, Otani J, Yamaguchi K, Fukumoto M, Hikasa H, Hagiwara S, Nishina H, Mak TW, Honma T, Kondoh Y, Osada H, Yoshida M, Suzuki A. Cancer Sci; 2021 Oct 01; 112(10):4303-4316. PubMed ID: 34289205 [Abstract] [Full Text] [Related]
29. Reactive oxygen species-mediated phosphorylation of p38 signaling is critically involved in apoptotic effect of Tanshinone I in colon cancer cells. Kim DH, Shin EA, Kim B, Shim BS, Kim SH. Phytother Res; 2018 Oct 01; 32(10):1975-1982. PubMed ID: 29876988 [Abstract] [Full Text] [Related]
30. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress. Maryam A, Mehmood T, Zhang H, Li Y, Khan M, Ma T. Sci Rep; 2017 Jul 24; 7(1):6242. PubMed ID: 28740138 [Abstract] [Full Text] [Related]
31. Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-κB pathways. He Y, Cao X, Kong Y, Wang S, Xia Y, Bi R, Liu J. Hum Exp Toxicol; 2019 Oct 24; 38(10):1132-1144. PubMed ID: 31203647 [Abstract] [Full Text] [Related]
32. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. Zheng H, Yang L, Kang Y, Chen M, Lin S, Xiang Y, Li C, Dai X, Huang X, Liang G, Zhao C. Mol Carcinog; 2019 Apr 24; 58(4):565-576. PubMed ID: 30520143 [Abstract] [Full Text] [Related]
33. Torilis japonica extract-generated intracellular ROS induces apoptosis by reducing the mitochondrial membrane potential via regulation of the AMPK-p38 MAPK signaling pathway in HCT116 colon cancer. Kim GT, Lee SH, Kim YM. Int J Oncol; 2016 Sep 24; 49(3):1088-98. PubMed ID: 27314881 [Abstract] [Full Text] [Related]
34. A comprehensive review of anticancer mechanisms of action of Alantolactone. Babaei G, Gholizadeh-Ghaleh Aziz S, Rajabi Bazl M, Khadem Ansari MH. Biomed Pharmacother; 2021 Apr 24; 136():111231. PubMed ID: 33454597 [Abstract] [Full Text] [Related]
35. Antitumor activity of alantolactone in lung cancer cell lines NCI-H1299 and Anip973. Liu J, Yang Z, Kong Y, He Y, Xu Y, Cao X. J Food Biochem; 2019 Sep 24; 43(9):e12972. PubMed ID: 31489665 [Abstract] [Full Text] [Related]
36. 2-(Pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl) thiophene induces apoptosis through reactive oxygen species-mediated JNK activation in human colon cancer SW620 cells. Xu DG, Lv W, Dai CY, Zhu FF, Xu GH, Ma ZJ, Chen Z. Anat Rec (Hoboken); 2015 Feb 24; 298(2):376-85. PubMed ID: 25178491 [Abstract] [Full Text] [Related]
37. Alantolactone inhibits oesophageal adenocarcinoma cells through nuclear factor erythroid 2-related factor 2-mediated reactive oxygen species increment. Chen J, Zhang Y, Huang R, Cao L, Zhang Y, Lian M, Wang Z, Jin J, Tang C, Chen T, Yan L, Yu L, Tian R, Xiang X, Luo L, Yu C. Basic Clin Pharmacol Toxicol; 2023 Mar 24; 132(3):253-262. PubMed ID: 36507595 [Abstract] [Full Text] [Related]
38. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice. Li X, Xia L, Ouyang X, Suyila Q, Su L, Su X. Protein Pept Lett; 2019 Mar 24; 26(7):512-522. PubMed ID: 30950338 [Abstract] [Full Text] [Related]
39. Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer. Wang B, Zhou TY, Nie CH, Wan DL, Zheng SS. Biochem Biophys Res Commun; 2018 May 05; 499(2):156-163. PubMed ID: 29548826 [Abstract] [Full Text] [Related]
40. Dioscin inhibits colon cancer cells' growth by reactive oxygen species-mediated mitochondrial dysfunction and p38 and JNK pathways. Li S, Cheng B, Hou L, Huang L, Cui Y, Xu D, Shen X, Li S. Anticancer Drugs; 2018 Mar 05; 29(3):234-242. PubMed ID: 29389802 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]